A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
Clinical trial NCT05160415 · COMPLETED
Trial details
- NCT number
- NCT05160415
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2024-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.